Francois Ghiringhelli

72PUBLICATIONS

268CO-AUTHORS

Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (72)

Sort by Publication Date:

|Jun 22, 2026

IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.

|Jun 20, 2026

Pooled analysis of 2 clinical trials of first-line chemoimmunotherapy for metastatic microsatellite stable colorectal cancer MEDITREME and METIMMOX studies.

|Jun 02, 2026

The mannosyltransferase DPM1 regulates the activity of ER-stress sensor IRE1 in colorectal cancer.

|May 13, 2026

Hapten-Based Cancer Immunotherapy: From Immune Activation to Antitumor Activity.

|May 08, 2026

Deep learning based on CD3 histological slides for prediction of colon cancer outcome: analysis of three international stage III colon cancer cohorts.

|Mar 30, 2026

Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met-Targeting Antibody-Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer.

John H Strickler, Judith Raimbourg, Jonathan E Cohen

Pageof 12

Frequent Collaborators

17 joint publications

Caroline Truntzer

10 joint publications

Cédric Rébé

10 joint publications

Romain Boidot

Nicolas Roussot

Frédérique Végran

Marion Thibaudin

Lionel Apetoh

Laurence Zitvogel

Thomas Aparicio

Corentin Richard

Frequent Collaborators

17 joint publications

Caroline Truntzer

10 joint publications

Cédric Rébé

10 joint publications

Romain Boidot

6 joint publications

Nicolas Roussot